E-LIB Suche - Ergebnisse für: de la Mora, Lorena

1

Toxic-Induced Encephalopathy Following Chemsex in a Young H..:

Inciarte, Alexy ; de la Mora, Lorena ; Huaier-Arriazu, Emilio...
Infectious Diseases and Therapy. 13 (2024) 4 - p. 647-658 , 2024

Link: https://doi.org/10.1007/..

2

Epidemiology, treatment and prognosis of HIV infection in 2..:

de la Mora, Lorena ; Mallolas, Josep ; Ambrosioni, Juan
Medicina Clínica (English Edition). 162 (2024) 11 - p. 535-541 , 2024

Link: https://doi.org/10.1016/..

3

Evolving AIDS- and non-AIDS Mortality and Predictors in the..:

Nomah, Daniel K ; Jamarkattel, Suju ; Bruguera, Andreu...
Open Forum Infectious Diseases. 11 (2024) 4 - p. , 2024

Link: https://doi.org/10.1093/..

4

Effectiveness, safety and discontinuation rates of bictegra..:

Chivite, Iván ; Berrocal, Leire ; de Lazzari, Elisa...
Journal of Antimicrobial Chemotherapy. , 2024

Link: https://doi.org/10.1093/..

5

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Non..:

Inciarte, Alexy ; Ugarte, Ainoa ; Martínez-Rebollar, María...
Open Forum Infectious Diseases. 10 (2023) 8 - p. , 2023

Link: https://doi.org/10.1093/..

6

Sex-based epidemiological and immunovirological characteris..:

Toyos, Sara ; Berrocal, Leire ; González-Cordón, Ana...
Eurosurveillance. 28 (2023) 10 - p. , 2023

Link: https://doi.org/10.2807/..

7

Increasing of New CA-MRSA Infections Detected in people liv..:

De La Mora, Lorena ; Pitart, Cristina ; Morata, Laura...
Infectious Diseases and Therapy. 12 (2023) 8 - p. 2179-2189 , 2023

Link: https://doi.org/10.1007/..

8

Experiencia de un programa de profilaxis preexposición en u..:

Laguno, Montserrat ; Ugarte, Ainoa ; Martinez-Rebollar, María...
Enfermedades Infecciosas y Microbiología Clínica. 41 (2023) 1 - p. 24-28 , 2023

Link: https://doi.org/10.1016/..

9

PrEP program experience in a hospital HIV unit. Description..:

Laguno, Montserrat ; Ugarte, Ainoa ; Martinez-Rebollar, María...
Enfermedades infecciosas y microbiologia clinica (English ed.). 41 (2023) 1 - p. 24-28 , 2023

Link: https://doi.org/10.1016/..

10

Perception of quality of care using patient reported experi..:

de Lazzari, Elisa ; Berrocal, Leire ; Fernández, Emma...
Medicine. 102 (2023) 14 - p. e33442 , 2023

Link: https://doi.org/10.1097/..

11

Efficacy and safety of raltegravir plus lamivudine maintena..:

Borjabad, Beatriz ; Inciarte, Alexy ; Chivite, Ivan...
Journal of Antimicrobial Chemotherapy. 79 (2023) 2 - p. 255-261 , 2023

Link: https://doi.org/10.1093/..

12

Clinical use and effectiveness of dolutegravir and lamivudi..:

Martínez-Serra, Adrián ; De Lazzari, Elisa ; Berrocal, Leire...
Journal of Antimicrobial Chemotherapy. 78 (2023) 8 - p. 1955-1962 , 2023

Link: https://doi.org/10.1093/..

13

Tolerability of bictegravir/tenofovir alafenamide/emtricita..:

Rocabert, Alba ; Borjabad, Beatriz ; Berrocal, Leire...
Journal of Antimicrobial Chemotherapy. 78 (2023) 12 - p. 2961-2967 , 2023

Link: https://doi.org/10.1093/..

14

Simplification from tenofovir disoproxil fumarate plus lami..:

Blanco, José L ; Rojas, Jhon ; de Lazzari, Elisa...
Journal of Antimicrobial Chemotherapy. 77 (2022) 7 - p. 1974-1979 , 2022

Link: https://doi.org/10.1093/..

15

C-reactive protein cut-off for early tocilizumab and dexame..:

Camon, Ana M. ; Alonso, Rodrigo ; Muñoz, Francisco J....
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..